Vitamin K

The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents

The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interference with vitamin K metabol...

The vitamin K therapeutic drug class comprises fat-soluble naphthoquinone compounds, most commonly formulated as phytonadione (vitamin K1), that serve as essential vitamin replacements and antihemorrhagic agents These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins

These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interferen...

These agents function as critical cofactors for the hepatic gamma-glutamyl carboxylase enzyme, enabling the post-translational activation of clotting factors II (prothrombin), VII, IX, and X, as well as endogenous anticoagulant proteins

Clinically, vitamin K is indicated to prevent and treat hemorrhagic disease of the newborn (vitamin K deficiency bleeding) and to correct hypoprothrombinemia secondary to malabsorption, nutritional deficiency, prolonged antibacterial therapy, or direct interference with vitamin K metabolism It additionally serves as the primary reversal agent for anticoagulant-induced coagulopathies caused by vitamin K antagonists such as warfarin

It additionally serves as the primary reversal agent for anticoagulant-induced coagulopathies caused by vitamin K antagonists such as warfarin